Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis E virus.

Subrat Kumar Panda1, Deepshi Thakral, Shagufta Rehman

  • 1Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India. subrat@gmail.com

Reviews in Medical Virology
|October 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blurring the Lines: NPM1 Mutation in Blast Phase CML Challenges Traditional Paradigms.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026
Same author

Therapy-related B-cell acute lymphoblastic leukemia after treatment for multiple myeloma.

American journal of blood research·2026
Same author

Implementation of tuberculosis care cascade among adult people living with HIV registered in anti-retroviral therapy centres in Odisha, India, 2020-2023.

BMC infectious diseases·2026
Same author

Single cell transcriptomics derived combinatorial markers distinguished leukemic stem cells from hematopoietic stem cells in acute myeloid leukemia.

Leukemia research·2026
Same author

Young Female With Shortness of Breath.

Journal of the American College of Emergency Physicians open·2025
Same author

CAR T-Cell Therapy: A Promising Modality for Autoimmune Diseases.

Indian pediatrics·2024

Hepatitis E virus (HEV) causes widespread hepatitis, particularly in developing nations, and poses risks to pregnant women. Research is advancing, but challenges remain in understanding HEV replication and pathogenesis.

Area of Science:

  • Virology
  • Hepatology
  • Public Health

Background:

  • Hepatitis E virus (HEV) is a significant cause of acute hepatitis globally, prevalent in Asia and increasingly recognized in developed countries.
  • It accounts for a substantial percentage of sporadic hepatitis cases in regions like the Indian subcontinent.
  • HEV infection is typically self-limiting but can lead to severe outcomes, including fulminant liver disease, especially in pregnant women.

Purpose of the Study:

  • To provide a comprehensive review of the current progress in Hepatitis E virus research.
  • To highlight the unanswered questions and challenges in understanding HEV biology, replication, and pathogenesis.
  • To summarize the genetic and structural characteristics of HEV and its classification.

Main Methods:

Related Experiment Videos

  • Review of existing scientific literature on Hepatitis E virus.
  • Analysis of HEV genome structure, including open reading frames (ORFs) and their functions.
  • Discussion of HEV classification, genotypes, and serotypes.

    • Main Results:

    • HEV is classified under the genus Hepevirus, family Hepeviridae, with four major genotypes and one serotype.
    • The HEV genome comprises three ORFs, encoding proteins involved in replication, capsid formation, and other functions.
    • While the HEV genome has been cloned and infectious replicons established, key aspects of its replication, transcription, and host interactions remain unclear.

    Conclusions:

    • Despite significant research progress, a reliable in vitro propagation system for HEV is still lacking, hindering a deeper understanding of its biology.
    • Further research is crucial to address fundamental questions regarding HEV replication, transcription, virus-host interactions, and pathogenesis.
    • The development of licensed antiviral drugs or vaccines for HEV is ongoing, with candidates in clinical trials.